"Authorized Generic Drugs, Price Competition and Consumers’ Welfare."

Berndt, Ernst R., Richard Mortimer, Ashoke Bhattacharjya, Andrew Parece and Edward Tuttle. Health Affairs Vol. 26, No. 3 (2007): 790-799.

"The United States' Experience with Direct-to-Consumer Advertising of Prescription Drugs: What Have We Learned?"

Berndt, Ernst R. In Pharmaceutical Innovation: Incentives, Competition, and Cost-Benefit Analysis in International Perspective, edited by Chee-Ruey Hsieh and Frank A. Sloan, 174-195. Cambridge, England: Cambridge University Press, 2007.

"The Value of Antihypertensive Drugs: A Perspective on Medical Innovation."

Cutler, David M., Genia Long, Ernst R. Berndt, Jimmy Royer, Andrée-Anne Fournier, Alicia Sasser and Pierre Cremieux. Health Affairs Vol. 26, No. 1 (2007): 97-110.

"Objective and Self-Report Work Performance Measures: A Comparative Analysis."

Pransky, Glenn, Stan Finkelstein, Ernst Berndt, Margaret Kyle, Joan Mackell and Dan Tortorice. International Journal of Productivity and Performance Management Vol. 55, No. 5 (2006): 390-399.

"Real Output in Mental Health Care During the 1990s."

Berndt, Ernst R., Alisa B. Busch, Richard G. Frank and Sharon-Lise Normand. Forum for Health Economics and Policy Vol. 9, No. 1 (2006): 1-2.

"The Impact of Incremental Innovation on Biopharmaceuticals: Drug Utilization in Original and Supplemental Indications."

Berndt, Ernst R., Iain M. Cockburn and Karen A. Grepin. PharmacoEconomics Vol. 24, No. S2 (2006): 69-86.